NDC 50261-313

ANNOVERA

Segesterone Acetate And Ethinyl Estradiol

ANNOVERA is a Vaginal Ring in the Human Prescription Drug category. It is labeled and distributed by Therapeuticsmd, Inc.. The primary component is Ethinyl Estradiol; Segesterone Acetate.

Product ID50261-313_17feae6d-baa1-4f2c-8989-c5400c2a1a88
NDC50261-313
Product TypeHuman Prescription Drug
Proprietary NameANNOVERA
Generic NameSegesterone Acetate And Ethinyl Estradiol
Dosage FormRing
Route of AdministrationVAGINAL
Marketing Start Date2019-08-12
Marketing CategoryNDA / NDA
Application NumberNDA209627
Labeler NameTherapeuticsMD, Inc.
Substance NameETHINYL ESTRADIOL; SEGESTERONE ACETATE
Active Ingredient Strength17 mg/1; mg/1
Pharm ClassesEstrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 50261-313-01

1 POUCH in 1 CARTON (50261-313-01) > 1 RING in 1 POUCH
Marketing Start Date2019-08-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50261-313-01 [50261031301]

ANNOVERA RING
Marketing CategoryNDA
Application NumberNDA209627
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-12

Drug Details

Active Ingredients

IngredientStrength
SEGESTERONE ACETATE103 mg/1

OpenFDA Data

SPL SET ID:37bb9ebd-2e99-4453-bbe6-9dd4a2897193
Manufacturer
UNII

Pharmacological Class

  • Estrogen Receptor Agonists [MoA]
  • Estrogen [EPC]

NDC Crossover Matching brand name "ANNOVERA" or generic name "Segesterone Acetate And Ethinyl Estradiol"

NDCBrand NameGeneric Name
12822-0313ANNOVERASEGESTERONE ACETATE, ETHINYL ESTRADIOL
50261-313ANNOVERAsegesterone acetate and ethinyl estradiol

Trademark Results [ANNOVERA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ANNOVERA
ANNOVERA
87849469 not registered Live/Pending
The Population Council, Inc.
2018-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.